NOS2 and neoplasm: Moreover, NOS2/COX2 inhibition produced profound changes in antitumor immunity that reduced both metastatic burden and tumor growth and led to increased cures and resistance to tumor rechallenge in the aggressive 4T1 mouse model (24).